Discovery Value Fund Crispr Therapeutics Ag Transaction History

Discovery Value Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$53.19 - $79.24 $1.68 Million - $2.51 Million	-31,637 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$70.09 - $111.29 $9.63 Million - $15.3 Million	-137,434 Reduced 81.29%	31,637 $2.4 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $1.87 Million - $2.66 Million	-17,000 Reduced 9.14%	169,071 $18.9 Million
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $18.8 Million - $30.1 Million	186,071 New	186,071 $30.1 Million

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.66B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Discovery Value Fund, based on Form 13F filings with the SEC.

Stay updated on Discovery Value Fund with notifications on news.